Chinese AI developer DeepSeek has accelerated IPO preparations following its record $7.4 billion private funding round in June 2026 at roughly $50 billion valuation. The Hangzhou-based large language model specialist is targeting a filing by year-end or early 2027 for a Shanghai STAR Market debut, while weighing additional capital at valuations near $74 billion. Its low-cost model releases have strengthened competitive positioning against U.S. frontier labs, though mainland regulatory requirements and U.S.-China tech tensions favor a domestic listing. Key near-term catalysts include completion of audited financials and any shifts in private fundraising momentum that could influence filing timelines.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$14,087 ปริมาณ
December 31, 2026
7%
March 31, 2027
36%
June 30, 2027
56%
September 30, 2027
73%
December 31, 2027
75%
$14,087 ปริมาณ
December 31, 2026
7%
March 31, 2027
36%
June 30, 2027
56%
September 30, 2027
73%
December 31, 2027
75%
The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If Deepseek is acquired by another company that is already public, this market will immediately resolve to "No."
The resolution source for this market is a consensus of credible reporting.
ตลาดเปิดเมื่อ: Jul 14, 2026, 8:01 PM ET
Resolver
0x65070BE91...The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If Deepseek is acquired by another company that is already public, this market will immediately resolve to "No."
The resolution source for this market is a consensus of credible reporting.
Resolver
0x65070BE91...Chinese AI developer DeepSeek has accelerated IPO preparations following its record $7.4 billion private funding round in June 2026 at roughly $50 billion valuation. The Hangzhou-based large language model specialist is targeting a filing by year-end or early 2027 for a Shanghai STAR Market debut, while weighing additional capital at valuations near $74 billion. Its low-cost model releases have strengthened competitive positioning against U.S. frontier labs, though mainland regulatory requirements and U.S.-China tech tensions favor a domestic listing. Key near-term catalysts include completion of audited financials and any shifts in private fundraising momentum that could influence filing timelines.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว

ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย